Antisense oligonucleotides (ASOs) are short, synthetic strands of nucleic acids designed to bind to specific sequences of RNA. By binding to their target RNA, ASOs can modulate gene expression, either by promoting degradation of the mRNA, inhibiting its translation, or modifying RNA splicing. This targeted approach has shown promise in treating a variety of genetic disorders, including those that affect neonates.
